Due to some unsubstantiated statements appearing in todays’ press, the company sets out to clarify that there is no delay in the access to the loan facility received from its largest shareholder Biopharma Invest AG on 14th November 2011.

In the announcement published on 14th November 2011, the Company informed among others to be working on a number of options to secure conclusion of additional fund raising. Due to the current financial market conditions and the lack of significant progress with the currently available options, the Company believes that it is appropriate to immediately implement certain restructuring measures, aimed at preserving the value of its core assets and which are part of the stricter austerity plan that had been prepared, as previously announced.

mondoBIOTECH holding AG (SIX: RARE) announces today that the Company has signed a subordinated and unsecured loan facility, granted to the Company by its largest shareholder, BioPharma Invest AG. The loan agreement allows the Company to access the facility as a credit line and the borrower to convert the loan into shares of the Company.